Actively Recruiting
Analysis of Inflammatory Biomarker Changes in Dry Blood Spot Versus Venous Blood Samples
Led by McGill University Health Centre/Research Institute of the McGill University Health Centre · Updated on 2026-03-27
50
Participants Needed
1
Research Sites
45 weeks
Total Duration
On this page
Sponsors
M
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead Sponsor
S
Sensifai Health
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to see whether dried blood spot (DBS) samples can measure inflammatory biomarkers as accurately as venous blood samples. Investigators will be measuring inflammatory biomarkers changes obtained in DBS compared with paired venous blood samples following a controlled physiological stressor (i.e. after a vaccine or other planned event that can cause a temporary rise in inflammation). These findings will help understand whether DBS can be a reliable alternative to traditional blood draws in future research and healthcare.
CONDITIONS
Official Title
Analysis of Inflammatory Biomarker Changes in Dry Blood Spot Versus Venous Blood Samples
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men or women aged 6518 years, planning to receive a seasonal vaccine or have a scheduled acute stressor (such as hard exercise, social event with moderate alcohol, medication change, menstruation onset, or other planned inflammatory stressors)
You will not qualify if you...
- Infectious symptoms (fever, cough, rhinorrhea, sore throat, diarrhea, loss of smell or taste) within the last 7 days
- Recent or active use of cocaine, injection drugs, or amphetamines
- Acute worsening of a known chronic health condition (e.g., inflammatory bowel disease, COPD, asthma, rheumatologic disease) within the last 30 days
- Known severe allergy or intolerance to the planned vaccine
- Contraindication to the vaccine received, if applicable
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Research Institute of the McGill University Health Centre
Montreal, Quebec, Canada, H4A 0B1
Actively Recruiting
Research Team
K
Kristen Moran, BSc.
CONTACT
E
Evelyn Laferrière, BSc.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here